Diabetes (2007) 56(11):274452
Eligibility depends on BMI, medical history, weight-related health concerns, current medications, contraindications, and provider judgment
Pros : Cons : What your doctor might consider Ozempic (semaglutide) is nearly identical to Wegovy, but heres the big difference: Its FDA-approved for Type 2 diabetes, not for weight loss
In a head-to-head study in adults with type 2 diabetes, Victoza demonstrated powerful A1C reductions after patients switched from Januvia 4 Primary endpoint: Mean change in A1C from baseline After 26 weeks Switch to Victoza after Januvia after Januvia Bailey (LIRA-SWITCH) Baseline A1C: 8.2% to 8.3% Studied in adults with type 2 diabetes taking metformin
And, it is not easy to burn calories, especially if you have a low-fat metabolism